FedEx Study Finds More Healthcare Customers Are Using Supply Chain to Stay Competitive
April 13 2015 - 9:00AM
Business Wire
FedEx Corp. (NYSE: FDX) today released Frost & Sullivan
research on the dynamics shaping the future healthcare supply
chain. The study, “Improving Profitability, Improving Customer
Loyalty, Improving Lives,” indicated that supply chain is a growing
and important differentiator for companies in the fast changing $3
trillion healthcare sector.
“Consolidation and other changes within the sector means
healthcare companies are experiencing growing financial and pricing
pressure,” said Carl Asmus, vice president, Global Supply Chain
Solutions and Market Development, FedEx Services. “More healthcare
companies are using their supply chain as a way to stand out from
their competitors and realize their financial goals.”
Over 80 percent of healthcare supply chain executives surveyed
at FedEx HealthCare Executive Forum agree supply chain is
‘extremely important’ to reaching profitability targets (89
percent) and revenue targets (83 percent), while 61 percent agree
cost reduction strategies in the supply chain have been ‘extremely
important’ in responding to customer pricing pressure.
“Product differentiation can take many forms beyond just the
specific clinical attributes of a product, and the supply chain
plays a critical role in separating one product from another,” said
Paul Higday, vice president, Marketing & Communications, Owens
& Minor, a healthcare logistics provider and FedEx customer.
“If a product is always available and delivered in an efficient and
cost effective manner, it’s harder for a competitor to take away
your market share.”
The release of the Frost & Sullivan paper coincides with the
launch of the new FedEx Global HealthCare Solutions website. To
access the site and view a full version of the Frost & Sullivan
report, visit www.fedex.com/healthcare.
Research Methodology
Frost & Sullivan designed and administered a survey to 39
high-level healthcare products and services executives attending
FedEx’s 2014 HealthCare Solutions Executive Forum October 28-29,
2014 in Miami. This information was supplemented with in-depth
interviews with selected executives to identify insights on the
dynamics shaping the future supply chain. The survey sample
included a broad range of companies cutting across the medical
device, diagnostic, pharmaceuticals and biotechnology segments as
well including major healthcare products distributors.
About FedEx Corp.
FedEx Corp. (NYSE: FDX) provides customers and businesses
worldwide with a broad portfolio of transportation, e-commerce and
business services. With annual revenues of $47 billion, the company
offers integrated business applications through operating companies
competing collectively and managed collaboratively, under the
respected FedEx brand. Consistently ranked among the world’s most
admired and trusted employers, FedEx inspires its more than 325,000
team members to remain “absolutely, positively” focused on safety,
the highest ethical and professional standards and the needs of
their customers and communities. For more information,
visit news.fedex.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in
collaboration with clients to leverage visionary innovation that
addresses the global challenges and related growth opportunities
that will make or break today’s market participants. For more than
50 years, we have been developing growth strategies for the global
1000, emerging businesses, the public sector and the investment
community. Is your organization prepared for the next profound wave
of industry convergence, disruptive technologies, increasing
competitive intensity, Mega Trends, breakthrough best practices,
changing customer dynamics and emerging economies?
FedEx Corp.Media Relations:Gretchen Mathis,
901-434-5701gretchen.mathis@fedex.com
FedEx (NYSE:FDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
FedEx (NYSE:FDX)
Historical Stock Chart
From Apr 2023 to Apr 2024